Johanna Friedl-Naderer
Equibles does not estimate personal net worth.
Get an email with a short summary when Dyne Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DYN alertsAbout Johanna Friedl-Naderer
Dyne Therapeutics, Inc. reported in an 8-K filed September 3, 2024 that Johanna Friedl-Naderer was appointed chief commercial officer. The proxy statement of Dyne Therapeutics, Inc. reports total compensation of $1,086,420 for Johanna Friedl-Naderer in fiscal 2025, including a base salary of $610,691. Disclosed compensation is on record for 2 fiscal years. Dyne Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dyne Therapeutics, Inc. includes John G. Cox (CEO and Board Member), Josh Brumm (CEO), Erick Lucera (CFO and Chief Accounting Officer) and 4 others.
“On September 3, 2024, the Company issued a press release announcing the hiring of Doug Kerr as chief medical officer, Johanna Friedl-Naderer as chief commercial officer and Lucia Celona as chief human resources officer and the resignations of Dr. McNeill, Ms. High and Wildon Farwell, the chief medical officer.”
Affiliation history
-
Dyne Therapeutics, Inc. (DYN)
Proxy statement
CurrentStart not stated–present
Last confirmed April 23, 2026
Company network
Leadership on record at Dyne Therapeutics, Inc.
- John G. Cox CEO, Board Member
- Josh Brumm CEO
- Erick Lucera CFO, Chief Accounting Officer
- Barry E. Greene Board Member
- Brian Posner Board Member
- Carlo Incerti, M.D. Board Member
- Vikram Karnani Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | $610,691 | $1,086,420 |
| 2024 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | $171,164 | $8,190,480 |